HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1- (methylsulfonylamino)- 3- (2- (4- methoxyphenyl)ethyl)- 4- (4- methoxyphenyl)- 2- imidazolidinone

structure in first source

Also Known As:

KVI 020; KVI-020; KVI020; WYE 160020; WYE-160020; WYE160020

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amides: 2428
  - Sulfonamides: 2809
    - 1-(methylsulfonylamino)-3-(2-(4-methoxyphenyl)ethyl)-4-(4-methoxyphenyl)-2-imidazolidinone: 1
- Sulfur Compounds: 278
  - Sulfones: 534
    - Sulfonamides: 2809
      - 1-(methylsulfonylamino)-3-(2-(4-methoxyphenyl)ethyl)-4-(4-methoxyphenyl)-2-imidazolidinone: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Imidazoles: 150
      - Imidazolidines: 39
        1-(methylsulfonylamino)-3-(2-(4-methoxyphenyl)ethyl)-4-(4-methoxyphenyl)-2-imidazolidinone: 1

Experts

1.	Blass, Benjamin E: 1 article (11/2009)
2.	Djandjighian, Laurent: 1 article (11/2009)
3.	Feingold, Irene: 1 article (11/2009)
4.	Fensome, Andrew: 1 article (11/2009)
5.	Gardell, Stephen J: 1 article (11/2009)
6.	Hennan, James: 1 article (11/2009)
7.	Ho, Douglas: 1 article (11/2009)
8.	Huselton, Christine: 1 article (11/2009)
9.	Jackson, Chris M: 1 article (11/2009)
10.	Janusz, John M: 1 article (11/2009)

Related Diseases

1.

Cardiac Arrhythmias (Arrythmia)

11/12/2009 - "KVI-020 (4g) successfully demonstrated antiarrhythmic efficacy in a canine arrhythmia model, and these findings support its utility as an antiarrhythmic agent."
11/12/2009 - "Selective Kv1.5 blockers: development of (R)-1-(methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a potential treatment for atrial arrhythmia."

Related Drugs and Biologics

1.	1- (methylsulfonylamino)- 3- (2- (4- methoxyphenyl)ethyl)- 4- (4- methoxyphenyl)- 2- imidazolidinone